Marvell's Insider Sales and Split Verdicts Expose the Gap Between Its Optics Boom and Custom-Silicon Ambitions
Published on 09/03/2026 at 08:11 | Editorial boerse-global.de
The chasm between where Marvell Technology generates its AI revenue today and where its long-term growth story is supposed to lead has rarely been wider — and the market's response is a study in contradiction. Record quarterly results, a pair of insider stock sales, and a rare four-way split among Wall Street analysts have converged to leave investors parsing whether the chipmaker is a bargain or a value trap in waiting.
The most telling data point comes from the company's own segment reporting. During the fiscal second quarter ended August 1, Marvell's datacenter revenue hit $2.17 billion, up 45.7% year over year and 18.5% sequentially. Within that, the electro-optics business — the components that shuttle data between servers — delivered $1.4 billion, a 97.2% surge. Custom AI chips, by contrast, contributed just $425 million, up a respectable but far less spectacular 43.1%. The optics franchise is now more than three times the size of the custom-silicon operation, and it is growing more than twice as fast.
That mix matters because the competitive landscape is moving in the opposite direction. Broadcom, Marvell's chief rival in custom silicon, reported AI chip revenue of $16.7 billion for its fiscal third quarter ended August 2 — more than triple the year-ago figure — with marquee customers including Google, Anthropic, and OpenAI. Broadcom has guided to $21.7 billion in the current quarter alone, a scale that underscores just how far Marvell's custom-chip business has to climb to be a meaningful contender in the AI infrastructure arms race.
Two Executives, Two Sales, One Message
Adding to the narrative noise, two members of Marvell's C-suite have trimmed their stakes within weeks of each other. President and COO Chris Koopmans sold 10,000 shares through a family trust on Tuesday of last week at a weighted average price of $203.27, netting roughly $2.03 million. The transaction was executed under a Rule 10b5-1 plan established in January — a pre-scheduled, automated strategy that typically carries less signaling weight than discretionary insider selling. The trust retains an indirect holding of 217,941 shares.
Just weeks earlier, CEO Matthew J. Murphy had sold 7,500 shares at a weighted average of $236.08, for approximately $1.77 million, under a plan set up in December 2025. Both sales are legally unremarkable. Psychologically, however, they land at an awkward moment: insider selling during a period of falling share prices rarely brightens sentiment, even when the transactions are clearly pre-arranged. The stock slipped 1.9% to $206.48 on the day Koopmans' sale was disclosed.
Should investors sell immediately? Or is it worth buying Marvell Technology?
Wall Street's Four-Way Argument
The analyst community has responded to the same set of results with strikingly divergent conclusions. Within days in late August, four firms staked out positions that span the full spectrum. Craig-Hallum reaffirmed its buy rating and lifted its price target aggressively from $217 to $300. B. Riley Securities trimmed its target from $345 to $315 but held firm at buy. TD Cowen nudged its target up to $245 while maintaining a hold. Cantor Fitzgerald confirmed a neutral stance with a $300 target.
The resulting range — $245 to $315, with ratings from buy to hold to neutral — signals a market that cannot agree on what Marvell is worth. Notably, the divergence does not appear to stem from fresh operational insights. The quarterly numbers have been public for weeks: total revenue of $2.74 billion, up 36.5%, net income of $308 million, up 58.1%, and adjusted earnings per share of $0.94, a penny ahead of consensus. The disagreement is philosophical, not factual. Analysts focused on growth trajectory see buying opportunities; those weighing valuation and customer concentration see reasons for caution.
A Stock Between Trend Lines
The share price tells the story of a market catching its breath. Marvell closed at €178.02, roughly 8% below its 50-day moving average of €193.79, yet still about 35% above its 200-day average — evidence that the medium-term uptrend remains intact despite recent softness. The stock sits approximately 39% below its 52-week high of €290.35, but has still gained 233% over the past twelve months. With 30-day realized volatility at 88% and an RSI of 43.5 — neither overbought nor oversold — the technical picture suggests consolidation rather than capitulation.
The Forward Calculus
Marvell's guidance points to a sharp acceleration: the company projects current-quarter revenue of $3.15 billion, up 51.8% year over year, with a full-fiscal-year 2027 target of $12 billion and $18 billion for fiscal 2028. The consensus analyst view remains a moderate buy with an average price target of $265.76.
The central question for investors is whether Marvell can close the gap between its optics-led present and its custom-silicon future. The company's own numbers show the optics business is carrying the growth burden today, while the custom-chip operation — the segment that will determine whether Marvell can compete for the largest AI infrastructure budgets — remains comparatively small. The bull case, articulated most forcefully by Craig-Hallum, holds that the current share price already discounts a meaningful portion of the risk. The bear case, implicit in the hold ratings from TD Cowen and Cantor Fitzgerald, is that patience will be tested before the custom-chip story matures into the revenue engine the valuation implies it must become.
For now, the market appears to be doing what markets do when narratives and numbers diverge: waiting for more evidence.
Ad
Marvell Technology Stock: New Analysis - 3 September
Fresh Marvell Technology information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
